Chronologic aging decreases tumor angiogenesis and metastasis in a mouse model of head and neck cancer

International Journal of Oncology

Volumn 36, Issue 3, 2010, Pages 715-723

  Bojovic, Bojana ^a   Crowe, David L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Angiogenesis; Cell cycle; Microarray; Necrosis; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; VASCULOTROPIN;

AGING; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CERVICAL LYMPH NODE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HEAD AND NECK CANCER; IMMUNE RESPONSE; INHIBITION KINETICS; LYMPH NODE METASTASIS; MALE; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIMARY TUMOR; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR VASCULARIZATION; WILD TYPE; ANIMAL; C57BL MOUSE; CELL AGING; CELL PROLIFERATION; DNA MICROARRAY; HEAD AND NECK TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); POLYPLOIDY; TUMOR CELL LINE;

AGING; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL AGING; CELL LINE, TUMOR; CELL PROLIFERATION; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYPLOIDY;

EID: 77149132127     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000547     Document Type: Article

References (29)

1. Balducci L and Ershler WB: Cancer and aging: a nexus at several levels. Nat Rev Cancer 5: 655-662, 2005.
2. Campisi J: Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120: 513-522, 2005.
3. Anisimov VN, Sikora E and Pawelec G: Relationships between cancer and aging: a multilevel approach. Biogerontology 10: 323-338, 2009.
4. Von Wagenheim KH and Peterson HP. Control of cell proliferation by progress in differentiation: clues to mechanisms of aging, cancer causation, and therapy. J Theor Biol 193: 663-678, 1998.
5. Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 414: 105-111, 2001.
6. Tomatis L: Cancer: causes, occurrence, and control. IARC Sci Publ 100. IARC, Lyon, 1990.
7. Derhovanessian E, Solana R, Larbi A and Pawelec G: Immunity, aging, and cancer. Immun Aging 15: 11, 2008.
8. + T cells in healthy HLA-A2+ donors. Eur J Immunol 35: 2876-2885, 2005.
9. Ku TKS and Crowe DL: Impaired T lymphocyte function increases tumorigenicity and decreases tumor latency in a mouse model of head and neck cancer. Int J Oncol 35: 1211-1221, 2009.
10. Mikhnin AE, Barchuk AS and Wagner RI: Kinetics of visual growth of skin melanoma. Russ Oncol J 2: 29-32, 2004.
11. Narita M and Lowe SW: Senescence comes of age. Nat Med 11: 920-922, 2005.
12. Sliwinska MA, Mosieniak G, Wolanin K, Babik A, Piwocka K, Magalska A, Szczepanowska J, Fronk J and Sikora E: Induction of senescence with doxorubicin leads to increased genomic instability of HCT116 cells. Mech Aging Dev 130: 24-32, 2009.
13. Jackson JG and Pereira-Smith OM: Primary and compensatory roles for Rb family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin induced senescence of breast cancer cells. Mol Cell Biol 26: 2501-2510, 2006.
14. te Poele RH, Okorokov AL, Jardine L, Cummings J and Joel SP: DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 62: 1876-1883, 2002.
15. Roberson RS, Kussick SJ, Vallieres E, Chen SY and Wu DY: Escape from therapy induced accelerated cellular senescence in p53 null lung cancer cells and in human lung cancers. Cancer Res 65: 2795-2803, 2005.
16. Berns A: Senescence: a companion in chemotherapy? Cancer Cell 1: 309-311, 2002.
17. Rebbaa A, Zheng X, Chu F and Mirkin BL: The role of histone acetylation versus DNA damage in drug induced senescence and apoptosis. Cell Death Differ 13: 1960-1967, 2006.
18. Storchova Z and Pellman D: From polyploidy to aneuploidy, genome instability, and cancer. Nat Rev Mol Cell Biol 5: 45-54, 2004.
19. Puig PE, Guilly MN, Bouchot A, Droin N, Cathelin D, Bouyer F, Favier L, Ghiringhelli F, Kroemer G, Solary E, Martin F and Chauffert B: Tumor cells can escape DNA damaging cisplatin through DNA endoreduplication and reversible polyploidy. Cell Biol Int 32: 1031-1043, 2008.
20. Ku TKS, Nguyen DC, Karaman M, Gill P, Hacia JG and Crowe DL: Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer. Mol Cancer Res 5: 351-362, 2007.
21. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, Teng SC and Wu KJ: Direct regulation of TWIST by HIF-1α promotes metastasis. Nat Cell Biol 10: 295-305, 2008.
22. Satoh K, Hamada S, Kimura K, Kanno A, Hirota M, Umino J, Fujibuchi W, Masamune A, Tanaka N, Miura K, et al: Upregulation of MSX2 enhances the malignant phenotype and is associated with twist 1 expression in human pancreatic cancer cells. Am J Pathol 172: 926-939, 2008.
23. Tanji Y, Osaki M, Nagahama Y, Kodani I, Ryoke K and Ito H: Runt related transcription factor 3 expression in human oral squamous cell carcinomas: implicatioin for tumor progression and prognosis. Oral Oncol 43: 88-94, 2007.
24. Ito Y: RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes. Adv Cancer Res 99: 33-76, 2008.
25. Koster MI, Kim S, Mills AA, DeMayo FJ and Roop DR: p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev 18: 126-131, 2004.
26. Giatromanolaki A, Koukourakis MI, Sivridis E, Gatter KC, Harris AL and Banham AH: Loss of expression and nuclear/ cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer: relationship with estrogen receptors in HIF-1α expression. Mod Pathol 19: 9-16, 2006.
27. Norhany S, Kouzu Y, Uzawa K, Hayama M, Higo M, Koike H, Kasamatu A and Tanzawa H: Overexpression of PAX5 in oral carcinogenesis. Oncol Rep 16: 1003-1008, 2006.
28. Wolf SS, Patchev VK and Obendorf M: A novel variant of the putative demethylase gene, s-JMJD1C, is a coactivator of the AR. Arch Biochem Biophys 460: 56-66, 2007.
29. Cui C, Elsam T, Tian Q, Seykora JT, Grachtchouk M, Dlugosz A and Tseng H: Gli proteins upregulate the expression of basonuclin in basal cell carcinoma. Cancer Res 64: 5651-5658, 2004.